Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neurocrine Biosciences (NBIX) Interest Coverage Ratio (2017 - 2024)

Historic Interest Coverage Ratio for Neurocrine Biosciences (NBIX) over the last 7 years, with Q1 2024 value amounting to 90.27.

  • Neurocrine Biosciences' Interest Coverage Ratio rose 18695.27% to 90.27 in Q1 2024 from the same period last year, while for Dec 2024 it was 518.64, marking a year-over-year increase of 62348.64%. This contributed to the annual value of 2.26 for FY2019, which is 8713.19% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Interest Coverage Ratio stood at 90.27 for Q1 2024, which was up 18695.27% from 128.36 recorded in Q3 2023.
  • In the past 5 years, Neurocrine Biosciences' Interest Coverage Ratio ranged from a high of 128.36 in Q3 2023 and a low of 103.82 during Q1 2023
  • For the 4-year period, Neurocrine Biosciences' Interest Coverage Ratio averaged around 20.44, with its median value being 8.21 (2020).
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first crashed by 14627.54% in 2020, then skyrocketed by 22936.93% in 2021.
  • Neurocrine Biosciences' Interest Coverage Ratio (Quarter) stood at 5.21 in 2020, then surged by 229.37% to 6.74 in 2021, then soared by 1803.82% to 128.36 in 2023, then fell by 29.67% to 90.27 in 2024.
  • Its Interest Coverage Ratio stands at 90.27 for Q1 2024, versus 128.36 for Q3 2023 and 56.62 for Q2 2023.